Granted Patent B2

US 8,231,912 · App. 12/771,246 · Granted Jul 31, 2012

Abstract

Claims (99)

1. A cleanser composition suitable for application to the skin and ocular surface comprising the following components in approximately the following concentrations as a percent by weight of the composition:

(a)

a blend of PEG-80, sorbitan laurate, sodium

0.5-10.0%;

trideceth sulfate, cocamidopropyl betaine,

sodium lauroamphoacetate, PEG-150 distearate,

and sodium laureth-13 carboxylate

(b)

Decyl Glucoside

0.2-10.0%;

(c)

Linalool

0.5-2.0%;

(d)

Cocamidopropyl PG-Dimonium Chloride

0.01-5.0%;

Phosphate

(e)

Trisodium EDTA

0.01-1.0%;

(f)

Allantoin

0.01-1.0%;

(g)

Panthenol

0.01-1.0%;

(h)

Hinokitiol

0.01-5.0%;

(i)

Tea Tree Oil

0.005-2.0%;

(j)

Vitamin E Acetate

0.005-2.0%;

(k)

Water

0.0-98.15%;

(l)

Dipropylene glycol

1.0-50.0%;

and

(m)

Cocamidopropyl betaine

0.1-20.0%.

2. The cleanser composition of claim 1 , wherein the cleanser composition is a applied as a foam, gel or liquid.

3. The cleanser composition of claim 1 , wherein the composition is for the treatment of an ocular disorder.

4. The cleanser composition of claim 3 , wherein the ocular disorder is dry eye, excessive bacteria on the eyelid dermis, Meibomian gland dysfunction (MGD), blepharitis, acne rosacea, scalp dandruff, seborrheic dermatitis, chalazion, hordeolum, sty infectious conjunctivitis, corneal ulcer, or demodex infestation.

5. The cleanser composition of claim 1 , wherein the ocular disorder is anterior or posterior blepharatis.

6. The cleanser composition of claim 1 , wherein the composition is effective against at least one of the following microorganisms: S. aureus, P. aeruginosa , B. catarrhalis, E. coli, S. marcescens, S. epidermidis , MRSA, and P. ovale.

7. The cleanser composition of claim 6 , wherein the S. aureus is methicillin resistant S. aureus.

8. The cleanser composition of claim 1 , wherein the cleanser composition is suitable for direct application to the ocular surface, an eyelid or the skin surrounding the eyelid of a subject.

9. The cleanser composition of claim 1 , wherein the cleanser comprises the following components in approximately the following amounts as a percent by weight of the composition:

(a)

a blend of PEG-80, sorbitan laurate, sodium

3.8%;

trideceth sulfate, cocamidopropyl betaine,

sodium lauroamphoacetate, PEG-150 distearate,

and sodium laureth-13 carboxylate

(b)

Decyl Glucoside

1.7% 

(c)

Linalool

0.9%;

(d)

Cocamidopropyl PG-Dimonium Choloride

0.2%;

Phosphate

(e)

Trisodium EDTA

0.1%;

(f)

Allantoin

0.1%;

(g)

Panthenol

0.1% 

(h)

Hinokitiol

0.05%;

(i)

Tea Tree Oil

0.025%;

(j)

Vitamin E Acetate

0.01%;

(k)

Water

68.215%;

(l)

Dipropylene glycol

23.0%;

and

(m)

Cocamidopropyl betaine

2.0%.

10. The cleanser composition of claim 1 , wherein the pH range is about 4.5-6.0.

11. The cleanser composition of claim 1 , wherein the pH range is about 5.3-5.7.

Assignments (23)